In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases.

Antimicrobial Agents and Chemotherapy
K ShannonI Phillips

Abstract

The in vitro activity of Ro 13-9904 was assessed against clinical isolated of common bacteria. Its activity against most enterobacteria was similar to that of cefotaxime and moxalactam, but it was even more active than these compounds against all Proteus species. It was also highly active against Haemophilus influenzae and Neisseria gonorrhoeae, including beta-lactamase producers. Like cefotaxime and moxalactam, Or 13-9904 was approximately eightfold more active than carbenicillin against most isolates of Pseudomonas aeruginosa and also active against highly carbenicillin-resistant isolates, but it was relatively inactive against moderately carbenicillin-resistant isolates. Ro 13-9904 also resembled cefotaxime and moxalactam in that it was active, though less so than cephaloridine, against staphylococci and streptococci, except for methicillin-resistant staphylococci and Streptococcus faecalis, which were resistant to it. It was less active than cefoxitin but slightly more active than ampicillin against both Bacteroides fragilis and other Bacteroides spp. Ro 13-9904 was resistant to most beta-lactamases but was attacked by enzymes from B. fragilis, isolates of indole-positive Proteus species, and also by a cefoxitin-hydrolyzing...Continue Reading

References


❮ Previous
Next ❯

Citations

Oct 1, 1983·European Journal of Clinical Microbiology·W M Scheld
Oct 1, 1983·European Journal of Clinical Microbiology·J D Baumgartner, M P Glauser
Feb 1, 1981·Antimicrobial Agents and Chemotherapy·L Verbist, J Verhaegen
Aug 1, 1981·Antimicrobial Agents and Chemotherapy·G BeskidP W Trown
Aug 1, 1981·Antimicrobial Agents and Chemotherapy·K OkonogiS Mitsuhashi
Nov 1, 1981·Antimicrobial Agents and Chemotherapy·I H PatelS A Kaplan
Dec 1, 1981·Antimicrobial Agents and Chemotherapy·R N JonesH W Wilson
Mar 1, 1982·Antimicrobial Agents and Chemotherapy·J S EpsteinG L Simon
Jul 1, 1982·Antimicrobial Agents and Chemotherapy·J W GnannC G Cobbs
Jul 1, 1982·Antimicrobial Agents and Chemotherapy·M J MaslowJ J Rahal
Nov 1, 1982·Antimicrobial Agents and Chemotherapy·A A PollockJ J Rahal
Jun 1, 1984·Antimicrobial Agents and Chemotherapy·R N JonesA L Barry
Jun 1, 1989·Antimicrobial Agents and Chemotherapy·G L JungbluthW J Jusko
May 15, 1989·American Journal of Ophthalmology·R Haimovici, T J Roussel
Dec 1, 1981·Antimicrobial Agents and Chemotherapy·H H HandsfieldK K Holmes
Feb 1, 1983·Antimicrobial Agents and Chemotherapy·M ArisawaH B Maruyama
Jan 1, 1992·Infection·H Knothe, P M Shah
Jan 1, 1985·Current Medical Research and Opinion·A M EmmersonM J Hall
Sep 1, 1984·The Journal of Pediatrics·E MartinK Stoeckel
Jan 1, 1991·Hospital Practice·D L Smith
Jun 1, 1985·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology·N Frimodt-MøllerV F Thomsen
Aug 6, 2010·The Journal of Toxicological Sciences·Anurag PayasiAnuj Bhatnagar
Dec 1, 1985·Drug Intelligence & Clinical Pharmacy·M C Nahata, W J Barson
Jan 1, 1991·Hospital Practice·P Pizzo
Aug 1, 1981·British Journal of Clinical Pharmacology·M E PickupV Wright
May 1, 1983·Antimicrobial Agents and Chemotherapy·L J EronD M Poretz
Jan 1, 1984·Antimicrobial Agents and Chemotherapy·B L Congeni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

© 2021 Meta ULC. All rights reserved